tiprankstipranks
Labcorp Holdings Inc. (CH:LH)
NYSE:LH
Switzerland Market

Labcorp Holdings (LH) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

LH Analyst Ratings

Strong Buy
8Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Labcorp
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LH Stock 12 Month Forecast

Average Price Target

$250.39
Based on 8 Wall Street analysts offering 12 month price targets for Labcorp Holdings in the last 3 months. The average price target is $250.39 with a high forecast of $269.90 and a low forecast of $234.34. The average price target represents a change from the last price of .
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
Highest Price Target$269.90Average Price Target$250.39Lowest Price Target$234.34
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Argus Research Analyst forecast on CH:LH
Argus Research
Argus Research
CHF250.51
Buy
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)
Mizuho Securities Analyst forecast on CH:LH
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
CHF258.59
Buy
Reiterated
05/27/26
Labcorp Holdings (LH) Gets a Buy from Mizuho Securities
Truist Financial Analyst forecast on CH:LH
Truist Financial
Truist Financial
CHF258.59
Buy
Reiterated
05/04/26
Analysts' Top Healthcare Picks: BrightSpring Health Services, Inc. (BTSG), Labcorp Holdings (LH)
Robert W. Baird Analyst forecast on CH:LH
Robert W. Baird
Robert W. Baird
CHF268.28CHF269.9
Buy
Reiterated
05/01/26
Labcorp price target raised to $334 from $332 at BairdLabcorp price target raised to $334 from $332 at Baird
Barclays Analyst forecast on CH:LH
Barclays
Barclays
CHF234.34
Hold
Assigned
05/01/26
Labcorp Holdings (LH) Gets a Hold from Barclays
Evercore ISI
CHF242.43
Buy
Reiterated
05/01/26
Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)
William Blair Analyst forecast on CH:LH
William Blair
William Blair
Buy
Reiterated
04/30/26
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Teladoc (TDOC)
Bank of America Securities Analyst forecast on CH:LH
Bank of America Securities
Bank of America Securities
CHF238.38
Buy
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Labcorp Holdings (NYSE: LH) and Bruker (NASDAQ: BRKR)
Piper Sandler Analyst forecast on CH:LH
Piper Sandler
Piper Sandler
CHF218.18CHF242.43
Hold
Reiterated
02/24/26
Labcorp Holdings (LH) Receives a Hold from Piper Sandler
Morgan Stanley Analyst forecast on CH:LH
Morgan Stanley
Morgan Stanley
CHF248.89
Buy
Reiterated
02/18/26
Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Labcorp Holdings (NYSE: LH) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on CH:LH
J.P. Morgan
J.P. Morgan
CHF257.78CHF266.67
Buy
Reiterated
02/18/26
Labcorp price target raised to $330 from $319 at JPMorganLabcorp price target raised to $330 from $319 at JPMorgan
Citi
CHF262.63
Buy
Reiterated
01/02/26
Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)
UBS
CHF262.63CHF258.59
Buy
Reiterated
10/29/25
Labcorp price target lowered to $320 from $325 at UBSLabcorp price target lowered to $320 from $325 at UBS
Leerink Partners Analyst forecast on CH:LH
Leerink Partners
Leerink Partners
CHF261.01CHF276.36
Buy
Reiterated
10/08/25
Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)
Jefferies
CHF242.43
Buy
Reiterated
07/25/25
Labcorp Holdings: Strong Financial Performance and Promising Outlook Justify Buy Rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Argus Research Analyst forecast on CH:LH
Argus Research
Argus Research
CHF250.51
Buy
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)
Mizuho Securities Analyst forecast on CH:LH
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
CHF258.59
Buy
Reiterated
05/27/26
Labcorp Holdings (LH) Gets a Buy from Mizuho Securities
Truist Financial Analyst forecast on CH:LH
Truist Financial
Truist Financial
CHF258.59
Buy
Reiterated
05/04/26
Analysts' Top Healthcare Picks: BrightSpring Health Services, Inc. (BTSG), Labcorp Holdings (LH)
Robert W. Baird Analyst forecast on CH:LH
Robert W. Baird
Robert W. Baird
CHF268.28CHF269.9
Buy
Reiterated
05/01/26
Labcorp price target raised to $334 from $332 at BairdLabcorp price target raised to $334 from $332 at Baird
Barclays Analyst forecast on CH:LH
Barclays
Barclays
CHF234.34
Hold
Assigned
05/01/26
Labcorp Holdings (LH) Gets a Hold from Barclays
Evercore ISI
CHF242.43
Buy
Reiterated
05/01/26
Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)
William Blair Analyst forecast on CH:LH
William Blair
William Blair
Buy
Reiterated
04/30/26
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Teladoc (TDOC)
Bank of America Securities Analyst forecast on CH:LH
Bank of America Securities
Bank of America Securities
CHF238.38
Buy
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Labcorp Holdings (NYSE: LH) and Bruker (NASDAQ: BRKR)
Piper Sandler Analyst forecast on CH:LH
Piper Sandler
Piper Sandler
CHF218.18CHF242.43
Hold
Reiterated
02/24/26
Labcorp Holdings (LH) Receives a Hold from Piper Sandler
Morgan Stanley Analyst forecast on CH:LH
Morgan Stanley
Morgan Stanley
CHF248.89
Buy
Reiterated
02/18/26
Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Labcorp Holdings (NYSE: LH) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on CH:LH
J.P. Morgan
J.P. Morgan
CHF257.78CHF266.67
Buy
Reiterated
02/18/26
Labcorp price target raised to $330 from $319 at JPMorganLabcorp price target raised to $330 from $319 at JPMorgan
Citi
CHF262.63
Buy
Reiterated
01/02/26
Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)
UBS
CHF262.63CHF258.59
Buy
Reiterated
10/29/25
Labcorp price target lowered to $320 from $325 at UBSLabcorp price target lowered to $320 from $325 at UBS
Leerink Partners Analyst forecast on CH:LH
Leerink Partners
Leerink Partners
CHF261.01CHF276.36
Buy
Reiterated
10/08/25
Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)
Jefferies
CHF242.43
Buy
Reiterated
07/25/25
Labcorp Holdings: Strong Financial Performance and Promising Outlook Justify Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Labcorp Holdings

3 Months
Erin WrightMorgan Stanley
Success Rate
16/22 ratings generated profit
73%
Average Return
+5.23%
Copying Erin Wright's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +5.23% per trade.
1 Year
Erin WrightMorgan Stanley
Success Rate
18/22 ratings generated profit
82%
Average Return
+14.32%
Copying Erin Wright's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +14.32% per trade.
2 Years
Erin WrightMorgan Stanley
Success Rate
20/22 ratings generated profit
91%
Average Return
+23.02%
Copying Erin Wright's trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +23.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LH Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
13
11
11
7
8
Hold
3
2
3
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
13
14
9
10
In the current month, LH has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LH average Analyst price target in the past 3 months is 250.39.
Each month's total comprises the sum of three months' worth of ratings.

LH Financial Forecast

LH Earnings Forecast

Next quarter’s earnings estimate for LH is $3.83 with a range of $3.74 to $4.01. The previous quarter’s EPS was $3.40. LH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.
Next quarter’s earnings estimate for LH is $3.83 with a range of $3.74 to $4.01. The previous quarter’s EPS was $3.40. LH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Sales Forecast

Next quarter’s sales forecast for LH is $2.97B with a range of $2.94B to $2.98B. The previous quarter’s sales results were $2.83B. LH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.
Next quarter’s sales forecast for LH is $2.97B with a range of $2.94B to $2.98B. The previous quarter’s sales results were $2.83B. LH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Stock Forecast FAQ

What is CH:LH’s average 12-month price target, according to analysts?
Based on analyst ratings, Labcorp Holdings Inc.’s 12-month average price target is 250.39.
    What is CH:LH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:LH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Labcorp Holdings Inc. a Buy, Sell or Hold?
        Labcorp Holdings Inc. has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Labcorp Holdings Inc.’s share price target?
          The average share price target for Labcorp Holdings Inc. is 250.39. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $269.90 ,and the lowest forecast is $234.34. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Labcorp Holdings Inc.?
            Labcorp Holdings Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
              How can I buy shares of Labcorp Holdings Inc.?
              To buy shares of CH:LH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.